Nicotine Normalizes Intracellular Subunit Stoichiometry of Nicotinic Receptors Carrying Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy

Download

index.pdf

Date

2009-05-01

Author

Son, Çağdaş Devrim
Cohen, Bruce N.
Lester, Henry A.

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

156
views

38
downloads

Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is linked with high penetrance to several distinct nicotinic receptor (nAChR) mutations. We studied (alpha 4)(3)(beta 2)(2) versus (alpha 4)(2)(beta 2)(3) subunit stoichiometry for five channel-lining M2 domain mutations: S247F, S252L, 776ins3 in alpha 4, V287L, and V287M in beta 2. alpha 4 and beta 2 subunits were constructed with all possible combinations of mutant and wild-type (WT) M2 regions, of cyan and yellow fluorescent protein, and of fluorescent and nonfluorescent M3-M4 loops. Sixteen fluorescent subunit combinations were expressed in N2a cells. Forster resonance energy transfer (FRET) was analyzed by donor recovery after acceptor photobleaching and by pixel-by-pixel sensitized emission, with confirmation by fluorescence intensity ratios. Because FRET efficiency is much greater for adjacent than for nonadjacent subunits and the alpha 4 and beta 2 subunits occupy specific positions in nAChR pentamers, observed FRET efficiencies from (alpha 4)(3)(beta 2)(2) carrying fluorescent alpha 4 subunits were significantly higher than for (alpha 4)(3)(beta 2)(2); the converse was found for fluorescent beta 2 subunits. All tested ADNFLE mutants produced 10 to 20% increments in the percentage of intracellular (alpha 4)(3)(beta 2)(2) receptors compared with WT subunits. In contrast, 24- to 48-h nicotine (1 mu M) exposure increased the proportion of (alpha 4)(3)(beta 2)(2) in WT receptors and also returned subunit stoichiometry to WT levels for alpha 4S248F and beta 2V287L nAChRs. These observations may be relevant to the decreased seizure frequency in patients with ADNFLE who use tobacco products or nicotine patches. Fluorescence-based investigations of nAChR subunit stoichiometry may provide efficient drug discovery methods for nicotine addiction or for other disorders that result from dysregulated nAChRs.

Subject Keywords

Molecular Medicine, Pharmacology

URI

https://hdl.handle.net/11511/41142

Journal

MOLECULAR PHARMACOLOGY

DOI

https://doi.org/10.1124/mol.108.054494

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells Karaman, Osman; Almammadov, Toghrul; Gedik, M. Emre; GÜNAYDIN, GÜRCAN; Kolemen, Safacan; Günbaş, Emrullah Görkem (Wiley, 2019-11-05) Two red-absorbing, water-soluble and mitochondria (MT)-targeting selenophene-substituted BODIPY-based photosensitizers (PSs) were realized (BOD-Se, BOD-Se-I), and their potential as photodynamic therapy (PDT) agents were evaluated. BOD-Se-I showed higher O-1(2) generation yield thanks to the enhanced heavy-atom effect, and this derivative was further tested in detail in cell culture studies under both normoxic and hypoxic conditions. BOD-Se-I not only effectively functioned under hypoxic conditions, but als...
Differential expressions and functions of phosphodiesterase enzymes in different regions of the rat heart DERİCİ, MEHMET KÜRŞAT; SADİ, GÖKHAN; Cenik, Basar; Güray, Nülüfer Tülün; DEMİREL YILMAZ, EMİNE (Elsevier BV, 2019-02-05) Phosphodiesterase enzymes (PDEs) are responsible for the adjustment of cyclic nucleotide levels. Alterations in PDE expressions in different tissues cause conflicts between functional and clinical effects of PDE inhibitors. Therefore, the aim of this study was to investigate the gene and protein expressions and the functional role of PDEs in atrium and ventricle of rat heart The expressions of PDEs were examined in cardiac intact tissues and enzymatically isolated cells. The effects of PDE1-5 inhibitors (vi...
Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-gamma Ligand in Chronic Cerebral Hypoperfusion SAYAN ÖZAÇMAK, HALE; SAYAN, Hale; BARUT, FİGEN; Jakubowska-Dogru, Ewa (Bentham Science Publishers Ltd., 2011-08-01) Chronic cerebral hypoperfusion can cause learning and memory impairment and neuronal damage resembling the effects observed in vascular dementia. PPAR-gamma agonists were shown to modulate inflammatory response and neuronal death following cerebral ischemia. The present study was designed to evaluate possible neuroprotective effects of rosiglitazone, a PPAR-gamma agonist, in rat model of chronic cerebral hypoperfusion. Cerebral hypoperfusion was induced by permanent bilateral occlusion of the common carotid...
2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent Milackova, Ivana; Prnova, Marta Soltesova; Majekova, Magdalena; Sotnikova, Ruzena; Stasko, Michal; Kovacikova, Lucia; Banerjee, Sreeparna; Veverka, Miroslav; Stefek, Milan (Informa UK Limited, 2015-02-01) The ability of flavonoids to affect multiple key pathways of glucose toxicity, as well as to attenuate inflammation has been well documented. In this study, the inhibition of rat lens aldose reductase by 3,7-di-hydroxy-2-[4-(2-chloro-1,4-naphthoquinone-3-yloxy)-3-hydroxyphenyl]-5-hydroxy-chromen-4-one (compound 1), was studied in greater detail in comparison with the parent quercetin (compound 2). The inhibition activity of 1, characterized by IC50 in low micromolar range, surpassed that of 2. Selectivity i...
Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity: A Randomised Trial Teik, Derek Ong Lai; Lee, Xiao Shiang; Lim, Chu Jian; Low, Chia Mei; Muslima, Mariyam; Aquili, Luca (Public Library of Science (PLoS), 2016-03-03) Background

Citation Formats

Ç. D. Son, B. N. Cohen, and H. A. Lester, “Nicotine Normalizes Intracellular Subunit Stoichiometry of Nicotinic Receptors Carrying Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy,” MOLECULAR PHARMACOLOGY, pp. 1137–1148, 2009, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/41142.